TrialMalaria journal2018

Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan.

Muzamil Mahdi Abdel Hamid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.